214 related articles for article (PubMed ID: 8241227)
1. Role of thromboxane and angiotensin in cyclosporine-induced renal vasoconstriction in the dog.
Carrier M; Tronc F; Pelletier LC; Latour JG
J Heart Lung Transplant; 1993; 12(5):851-5. PubMed ID: 8241227
[TBL] [Abstract][Full Text] [Related]
2. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
3. Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
Hvistendahl JJ; Pedersen TS; Djurhuus JC; Pedersen EB; Frøkiaer J
Urol Res; 2002 Jul; 30(3):169-77. PubMed ID: 12111180
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II influences the renal hemodynamic response to blockade of thromboxane A2 and prostaglandin H2 receptors.
Yamaguchi Y; Fenoy FJ; Roman RJ; Nasjletti A
J Pharmacol Exp Ther; 1992 Dec; 263(3):905-9. PubMed ID: 1469647
[TBL] [Abstract][Full Text] [Related]
5. Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat.
Perico N; Dadan J; Remuzzi G
J Am Soc Nephrol; 1990 Jul; 1(1):76-83. PubMed ID: 2104254
[TBL] [Abstract][Full Text] [Related]
6. Role of thromboxane TP and angiotensin AT1 receptors in lipopolysaccharide-induced arterial dysfunction in the rabbit: an in vivo study.
Vayssettes-Courchay C; Ragonnet C; Camenen G; Félétou M; Cordi AA; Lavielle G; Verbeuren TJ
Eur J Pharmacol; 2010 May; 634(1-3):113-20. PubMed ID: 20202467
[TBL] [Abstract][Full Text] [Related]
7. Blockade of cyclosporine-induced vasoconstriction by the calcium channel blocker diltiazem in dogs.
Carrier M; Tronc F; Stewart D; Nattel S; Pelletier LC
J Thorac Cardiovasc Surg; 1993 Sep; 106(3):487-90. PubMed ID: 8361192
[TBL] [Abstract][Full Text] [Related]
8. [Effect of therapeutic doses of cyclosporine injected into the renal and femoral arteries in dogs].
Tronc F; Carrier M; Pelletier LC
Ann Chir; 1991; 45(9):827-32. PubMed ID: 1664194
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
10. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
Galle J; Schollmeyer P; Wanner C
Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762
[TBL] [Abstract][Full Text] [Related]
12. Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
Abels BC; Branch RA; Sabra R
J Pharmacol Exp Ther; 1993 Mar; 264(3):1285-92. PubMed ID: 8450463
[TBL] [Abstract][Full Text] [Related]
13. Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: Role of arterial baroreflexes and vasoreactivity.
Nasser SA; Sabra R; Elmallah AI; El-Din MM; Khedr MM; El-Mas MM
Life Sci; 2016 Oct; 163():1-10. PubMed ID: 27575704
[TBL] [Abstract][Full Text] [Related]
14. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
15. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane A2 does not mediate angiotensin II-dependent nonischemic peripheral vasoconstriction in healthy men: a pilot study.
Gasic S; Eichler HG; Kyrle PA; Wolzt M; Eidenberger T; Vierhapper H
Int J Clin Pharmacol Ther; 1997 Feb; 35(2):56-60. PubMed ID: 9147708
[TBL] [Abstract][Full Text] [Related]
17. Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system.
Larson TS; Hudson K; Mertz JI; Romero JC; Knox FG
J Lab Clin Med; 1983 Mar; 101(3):385-91. PubMed ID: 6338138
[TBL] [Abstract][Full Text] [Related]
18. Conjugate effects of saralasin and indomethacin on kidney function in anesthetized dog.
Tost H; Kövér G; Darvasi A
Acta Physiol Hung; 1995; 83(1):63-77. PubMed ID: 7660839
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term high-saturated and unsaturated fatty acid diets on relaxation and contraction of renal arteries in insulin resistant rats.
Gao Y; Song GY; Ma HJ; Zhang WJ; Zhou Y
Sheng Li Xue Bao; 2007 Jun; 59(3):363-8. PubMed ID: 17579794
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
Handa RK; Strandhoy JW
J Pharmacol Exp Ther; 1996 Jun; 277(3):1486-91. PubMed ID: 8667214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
